Skip to content
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled […]
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
While it deliberates on whether to support the expansion of the international waiver of IP protections for COVID-19 therapeutics and diagnostics, the United States
Last chance for public hearing on the COVID IP waiver expansion Read More »
A broad coalition of 65 national and state agriculture and bioscience organizations, including the Biotechnology Innovation Organization (BIO), expressed their gratitude in a letter
USTR action to address Mexico corn ban strongly supported by ag & bioscience groups Read More »
Experts told a House subcommittee Wednesday that China’s government coordinates a strategy to steal U.S. intellectual property – and the waiver of COVID IP would
Congress shines a light on China’s strategy to steal U.S. IP Read More »
On March 6, 2023, the United States Trade Representative (USTR) made a request for technical consultations concerning Mexico’s biotech corn ban under the U.S.-Mexico-Canada
U.S. takes step toward legal resolution of Mexico’s biotech corn ban Read More »
With the emergence of COVID-19 and the lack of timely response, the international community instantly realized that a foolproof plan for future pandemics is
Pharma recommends five essential priorities for future pandemic preparedness Read More »
Vulnerability to the impacts of climate change has been studied extensively in recent years but two new studies highlight specific impacts of changing weather
Human health seriously impacted by changing weather and air pollution Read More »
Mexico yesterday announced a modified decree regarding U.S. imports of biotech corn for animal feed. However, the change does not appear to stop the ban on
UPDATED: Mexico issues modified decree on biotech corn – but it’s not enough Read More »
Last week, Reuters reported that Doug McKalip, the new U.S. Trade Representative’s (USTR) Chief Agricultural Trade Negotiator, told Mexico that it has “until Feb.
Mexico needs to ‘explain the science’ behind its corn ban Read More »
“I think we’re in a very exciting time in healthcare and biotech,” said Steven Ladd, Director of Business Development and Acquisitions at AbbVie. “It’s
China-U.S. biotech ventures are where collaboration meets competition Read More »
